Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Niosomes can effectively deliver cetirizine topically for treating alopecia.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.